Benefits of Self-Testing

Self-monitoring / self-testing is the name given to the methods used by patients to test their own INR. The technology available for self-testing has improved greatly in recent years and results generally follow those generated by the laboratory. Dosing adjustments are still carried out by a qualified physician, but patients can often avoid unnecessary visits to see the doctor. 

In 2006, a paper published in the Lancet reviewed many different clinical studies from around the world, showed significantly fewer negative outcomes and an improved quality of life in patients self testing on oral anticoagulation therapy than those who self-tested as compared to those who were tested by conventional laboratory/clinic means. The benefits of moving from having a venous sample taken to finger stick sample plus having a reduced need to spend time in a clinic has resulted in more people on long-term OAT choosing self-testing. 

The CoagLite® instrument using SmartStrip® technology allows you to self-test in a significantly easier and less painful manner than ever before. Taking our cues from the blood glucose testing industry, we have designed a system with the patient in mind that allows the patient to take the meter to their finger rather than having to manipulate their finger towards the meter. 

The Lancet review was updated in 2011 and showed again:

Reduction of adverse events in patients who self monitor their oral coagulation as compared to “usual care”

Reduction in Thromboembolic events – 50%
Reduction in Major Haemorrhagic events 12%
Reduction in Death – 18%
<55 yrs 67% reduction in thrombotic events
Mech Heart Valve – 48% reduction in thrombotic events

Reference
The Lancet Dec 2011 Heneghan, Ward, Perera
‘Self-monitoring of oral anticoagulation:systematic review and meta analysis of individual patient data;'